Clinical Trial Update: Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Vandetanib with bicalutamide versus bicalutamide alone in chemotherapy-naive hormone-refractory prostate cancer, focusing on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Vandetanib (vandetanib)
• bicalutamide (bicalutamide)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED